|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.080 USD | 0.00% |
|
+4.62% | +102.99% |
| 06-18 | Chardan Raises Price Target on Opus Genetics to $13 From $11, Keeps Buy Rating | MT |
| 06-16 | Opus Genetics, Inc. - Special Call |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | 0.00% | +4.62% | -0.24% | -11.11% | +102.99% | +350.23% | +4.35% | -15.53% | - | 332M | |
| +0.45% | -1.37% | +3.98% | +21.58% | +3.01% | +43.66% | +141.28% | +409.94% | +1,397.27% | 983B | |
| +3.37% | +1.66% | +3.87% | +1.55% | +15.53% | +58.00% | +44.48% | +47.01% | +103.68% | 557B | |
| +2.07% | +5.52% | +10.15% | +14.56% | +2.74% | +27.75% | +72.72% | +105.93% | +282.91% | 406B | |
| +1.53% | -1.93% | -4.39% | +6.28% | -2.56% | +23.33% | +16.35% | -7.38% | +29.84% | 314B | |
| +2.26% | +2.95% | -2.34% | -2.20% | -1.45% | +30.77% | +17.16% | +62.75% | +249.63% | 273B | |
| +2.61% | +2.66% | +3.31% | +6.76% | +12.61% | +30.07% | +37.04% | +43.86% | +60.60% | 272B | |
| +2.60% | +7.76% | +6.49% | +29.61% | -5.38% | -35.32% | -43.32% | +19.91% | +77.02% | 203B | |
| +0.66% | -0.24% | +3.30% | -0.79% | +6.02% | +27.37% | +52.79% | +45.37% | +127.89% | 186B | |
| +0.14% | -1.71% | -6.49% | -8.95% | +1.88% | +17.76% | +61.42% | +87.62% | +49.99% | 155B | |
| -1.44% | -5.07% | -4.37% | -7.66% | -0.72% | +2.87% | -35.46% | -36.70% | -28.53% | 143B | |
| +0.35% | +3.37% | +7.45% | +3.81% | +3.32% | +5.61% | +34.99% | +149.80% | +431.09% | 118B | |
| +1.52% | -0.70% | -4.31% | -2.58% | +2.95% | +18.35% | -14.62% | -14.91% | -23.55% | 112B | |
| +1.35% | -2.74% | -4.44% | -5.55% | -11.18% | -11.72% | -24.74% | -16.25% | +3.23% | 99.57B | |
| +1.71% | -0.03% | +2.22% | +0.36% | +7.29% | +39.57% | +44.04% | +12.27% | +10.32% | 102B | |
| -1.17% | +0.08% | -8.11% | -14.06% | -9.81% | +3.41% | +74.34% | +70.11% | +516.93% | 76.7B | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | |
| +0.72% | -1.51% | -1.92% | -13.12% | +3.64% | +16.86% | +9.20% | +33.56% | +13.58% | 48.69B | |
| -0.77% | +2.30% | -2.95% | -11.17% | -17.78% | -5.37% | +5.56% | -30.51% | +232.00% | 48.18B | |
| +1.10% | +6.31% | +0.23% | +0.56% | +4.30% | +44.65% | -23.56% | -24.76% | -57.97% | 42.93B | |
| Average | +0.96% | -0.16% | +0.08% | +0.41% | +6.18% | +36.20% | +24.95% | +49.58% | +193.11% | 210.26B | |
| Weighted average by Cap. | +1.34% | -1.88% | +2.10% | +7.73% | +3.45% | +28.95% | +55.17% | +130.36% | +430.29% |
- Stock Market
- Stocks
- IRD Stock
- Sector Opus Genetics, Inc.
Select your edition
All financial news and data tailored to specific country editions
